FDA Warns Of Suicide Risk Linked To Montelukast Singulair

Armen Hareyan's picture
Advertisement

FDA is investigating a possible association between the use of Singulair and behavior/mood changes, suicidality (suicidal thinking and behavior) and suicide.

Advertisement